试用视觉搜索
使用图片进行搜索，而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索，请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等（默认）
关闭
筛选器
960×540
pharmaphorum.com
Makary confirmed as Trump's FDA pick, with Weldon for CDC | pharmaphorum
960×540
pharmaphorum.com
Novartis bid to block generic Entresto in US suffers setback | pharmaphorum
840×473
pharmaphorum.com
Sanofi's tolebrutinib cuts MS progression by 31% in trial | pharmaphorum
1200×675
pharmaphorum.com
Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn | pharmaphorum
1200×675
pharmaphorum.com
Advanz Pharma's bid to keep Ocaliva on EU market fails | pharmaphorum
960×540
pharmaphorum.com
ASH: MSD’s ROR1 drug hits the target in first-line lymphoma | pharmaphorum
960×540
pharmaphorum.com
FDA says yes to MSD’s 21-valent adult pneumococcal jab | pharmaphorum
960×540
pharmaphorum.com
PBC drug choices rise in US with OK for Gilead's seladelpar | pharmaphorum
1200×675
pharmaphorum.com
GSK to move HQ to central London, as Canary Wharf plans filed | pharmaphorum
1200×675
pharmaphorum.com
FDA says yes to MSD’s 21-valent adult pneumococcal jab | pharmaphorum
1200×675
pharmaphorum.com
Lundbeck planning for four novel drugs in phase 3 in 2026 | pharmaphorum
960×540
pharmaphorum.com
Adcendo licenses Multitude anti-TF ADC in $1bn+ deal | pharmaphorum
1200×675
pharmaphorum.com
AbbVie gets continuous Parkinson's drug over the line in US | pharmaphorum
960×540
pharmaphorum.com
AI firm Generate signs $1bn discovery deal with Novartis | pharmaphorum
960×540
pharmaphorum.com
Sanofi to invest €1bn in France to lift ‘health sovereignty’ | pharmaphorum
1200×675
pharmaphorum.com
AbbVie gets continuous Parkinson's drug over the line in US | pharmaphorum
1600×900
pharmaphorum.com
Threats impacting the pharmaceutical industry in 2024 | pharmaphorum
1200×675
pharmaphorum.com
PBM reform looms in end-of-year US legislation package | pharmaphorum
1200×675
pharmaphorum.com
OrbiMed raises $4.3bn for latest biotech funds | pharmaphorum
1200×675
pharmaphorum.com
FDA kicks off review of Cytokinetics' aficamten for HCM | pharmaphorum
1200×675
pharmaphorum.com
Vertex eyes FDA decision on non-opioid pain drug in January | pharmaphorum
960×540
pharmaphorum.com
AbbVie breaks new ground for IL-23 drug Skyrizi in IBD | pharmaphorum
1200×675
pharmaphorum.com
AbbVie breaks new ground for IL-23 drug Skyrizi in IBD | pharmaphorum
900×500
pharmaphorum.com
Elon Musk’s Neuralink brain interface chip set for human trials | pharmaphorum
1200×675
pharmaphorum.com
Ipsen doubles up in TCEs for cancer, adding Biomunex drug | pharmaphorum
960×540
pharmaphorum.com
In shock move, EU panel rejects Alzheimer's drug Leqembi | pharmaphorum
1200×675
pharmaphorum.com
SNIPR shoots down resistant E. coli in first human trial | pharmaphorum
2133×1600
deep-dive.pharmaphorum.com
Timeline: a history of medical imaging - pharmaphorum
960×540
pharmaphorum.com
Pfizer’s new cancer unit sees eight new blockbusters by 2030 | pharmaphorum
960×540
pharmaphorum.com
Roche trumpets new fenebrutinib data in relapsing MS | pharmaphorum
1200×675
pharmaphorum.com
Generative AI in clinical trials: Practical use cases and common concerns | phar…
1200×675
pharmaphorum.com
Biotech Showcase marking 17 years of innovation and opportunity | pharmaphorum
1200×675
pharmaphorum.com
PBM reform dropped in Congress' funding package | pharmaphorum
960×540
pharmaphorum.com
GSK plans phase 3 for hepatitis B drug bepirovirsen, despite efficacy drop | pharmaphorum
2048×1365
pharmaphorum.com
Sanofi doubles down on mRNA jabs with €400m-a-year R&D drive | pharmaphorum
某些结果已被隐藏，因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
反馈
反馈
